Skip to content

Drug interactions

Ondansetron + Tepotinib

Severity: Minor

Ondansetron and Tepotinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tepotinib inhibits P-glycoprotein and may increase exposure to P-gp substrates. Ondansetron is only a weak P-gp substrate, so any increase is likely small, though ondansetron has dose-related QT effects.

What this interaction means in plain words

Ondansetron and Tepotinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ondansetron belongs to Gastrointestinal Tract; Tepotinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of intestinal P-glycoprotein by tepotinib may modestly increase ondansetron absorption.

What to do

No dose adjustment is usually needed. Monitor for adverse effects such as headache, constipation or QT symptoms, especially in patients with cardiac risk factors.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ondansetron and Tepotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ondansetron with Tepotinib?

MediHelp rates the interaction as minor. Ondansetron and Tepotinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tepotinib inhibits P-glycoprotein and may increase exposure to P-gp substrates. Ondansetron is only a weak P-gp substrate, so any increase is likely small, though ondansetron has dose-related QT effects.

How serious is the interaction between Ondansetron and Tepotinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is usually needed. Monitor for adverse effects such as headache, constipation or QT symptoms, especially in patients with cardiac risk factors.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in